lactic acid and abacavir

lactic acid has been researched along with abacavir in 4 studies

Research

Studies (4)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	4 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Asboe, D; Datta, D; Gazzard, BG; Mandalia, S; Morlese, J; Moyle, GJ	1
Blanco, F; de la Cruz, JJ; García-Benayas, T; González-Lahoz, J; Soriano, V	1
Bastow, B; Glesby, MJ; Gulick, RM; Kuritzkes, DR; Meyer, WA; Ribaudo, HJ; Shikuma, CM; Tashima, KT; Webb, N; Yang, Y	1
Melkaoui, K; Setzer, B; Venhoff, N; Walker, UA	1

Trials

1 trial(s) available for lactic acid and abacavir

Article	Year
Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095). Journal of acquired immune deficiency syndromes (1999), 2007, Apr-15, Volume: 44, Issue:5 Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Glucose; Body Composition; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Insulin Resistance; Lactic Acid; Lamivudine; Lipids; Male; Reverse Transcriptase Inhibitors; Zidovudine	2007

Article

Year

Metabolic effects of protease inhibitor-sparing antiretroviral regimens given as initial treatment of HIV-1 Infection (AIDS Clinical Trials Group Study A5095).

Journal of acquired immune deficiency syndromes (1999), 2007, Apr-15, Volume: 44, Issue:5

Topics: Adult; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; Blood Glucose; Body Composition; Cyclopropanes; Dideoxynucleosides; Double-Blind Method; Female; HIV Infections; HIV-1; Humans; Insulin Resistance; Lactic Acid; Lamivudine; Lipids; Male; Reverse Transcriptase Inhibitors; Zidovudine

2007

Other Studies

3 other study(ies) available for lactic acid and abacavir

Article	Year
Hyperlactataemia and lactic acidosis during antiretroviral therapy: relevance, reproducibility and possible risk factors. AIDS (London, England), 2002, Jul-05, Volume: 16, Issue:10 Topics: Acidosis, Lactic; Adult; Anti-HIV Agents; Cross-Sectional Studies; Didanosine; Dideoxynucleosides; Female; HIV Infections; Humans; Lactic Acid; Longitudinal Studies; Male; Multivariate Analysis; Prospective Studies; Reproducibility of Results; Risk Factors; Sex Factors; Thymidine	2002
Replacing stavudine by abacavir reduces lactate levels and may improve lipoatrophy. AIDS (London, England), 2003, Apr-11, Volume: 17, Issue:6 Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Case-Control Studies; Dideoxynucleosides; Female; Follow-Up Studies; HIV Reverse Transcriptase; HIV-Associated Lipodystrophy Syndrome; Humans; Lactic Acid; Male; Middle Aged; Prospective Studies; Reverse Transcriptase Inhibitors; Stavudine	2003
Mitochondrial toxicity of tenofovir, emtricitabine and abacavir alone and in combination with additional nucleoside reverse transcriptase inhibitors. Antiviral therapy, 2007, Volume: 12, Issue:7 Topics: Adenine; Anti-HIV Agents; Cell Line, Tumor; Cell Proliferation; Cell Survival; Deoxycytidine; Dideoxynucleosides; DNA, Mitochondrial; Emtricitabine; Humans; Lactic Acid; Lipid Metabolism; Mitochondria; Organophosphonates; Reverse Transcriptase Inhibitors; Tenofovir	2007